The GI Oncology Now team is onsite at the 2025 American Society of Clinical Oncology Annual Meeting, providing real-time coverage of the most relevant and practice-changing research updates related to a variety of gastrointestinal malignancies.
Advertisement
Latest News
Dr. Reni breaks a randomized phase III trial of pre-operative chemotherapy with mFOLFIRINOX or PAXG for stage I-III PDAC.
Adjuvant nivolumab provides durable long-term DFS benefit and shows an OS advantage in patients with resected EC/GEJC.
Long-term follow-up from KEYNOTE-016 explores pembrolizumab treatment in dMMR/MSI-H solid tumors in advanced CRC.
The addition of concurrent chemoradiation to chemotherapy can improve OS and resection rates in patients with LAGBC.
The Claudin18.2 antibody-drug conjugate IBI343 is well tolerated and shows encouraging efficacy in patients with PDAC.
LEAP-002 long-term follow-up suggests there may be benefit associated with len/pembro for patients with aHCC.
Dina Ioffe, MD, Fox Chase Cancer Center, talks about the use of immunotherapy in the neoadjuvant or adjuvant setting.
Sotorasib with panitumumab and FOLFIRI has shown promising long-term efficacy results in pretreated KRAS G12C–mutated ...
Researchers evaluated the efficacy and safety of hepatic arterial infusion chemotherapy as a first-line treatment option.
Pembro plus lenvatinib with chemo may improve progression-free survival in patients when compared with the standard of care.
Advertisement
Advertisement
Editorial Advisory Board
Christopher Lieu, MDEditor | Co-Director of Gastrointestinal Medical Oncology at University of Colorado Medicine
Benjamin Weinberg, MD, FACPEditor | Associate Professor of Medicine at Lombardi Comprehensive Cancer Center
Zev Wainberg, MD, MScEditor | Co-Director of Gastrointestinal Oncology at the University of California, Los Angeles
Roundtable Discussions
Conference Coverage
The latest news and research updates in GI cancer treatment from the ASCO 2025 Annual Meeting.
GI Oncology Now reviews education from ASCO GI 2025, featuring the latest advances in the field of GI cancer research.
Coverage of the 2025 ASCO GI Symposium, with a focus on liver cancer
GI Oncology Now reviews education from ASCO GI 2024, featuring the latest advances in the field of GI cancer research.
The latest news and research updates in GI cancer treatment from the ASCO 2024 Annual Meeting
The latest news and research updates in GI cancer treatment from the ESMO Congress 2024
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.